“For sale” Fresenius creates new $2.4bn business

As Germany-based healthcare conglomerate Fresenius looks to simplify the group's structure, selling off non-core parts of a business which currently spans hospitals, dialysis, pharma, rehabilitation and more, it is building a $2.4bn new business partnership in the US. We speak to an EU-based source familiar with Fresenius to put this all in context.

Interview: Dagmar Dvorakova, CEO and Prof. Dr. Roland Staudinger, managing director, Aquilia Health Group

Smart reha, medical malls, how to best deploy new medtech, Fresenius Vamed veterans both, Dagmar and Roland are full of ideas on how to best build and run health care service models from acute hospitals to rehab and outpatient. Two and a half years ago they quit the mothership to set up Aquila which now employs 45 and runs projects in China, SE Asia, Austria, Germany and the Czech Rep.

India’s Unicorns and Soonicorns

India’s health startups have attracted crazy levels of investment, creating five unicorns in a year, with more to follow. HBI takes a closer look.

Health care tourism market recovering fast in Thailand

Thai healthcare tourism is set to recover in 2022, after the dive caused by the restrictions in international traffic caused by the COVID pandemic, say analysts. We look at the results for listed hospital group Bumrungrad, which has built its business on medical tourism and cares for over 1.1m patients a year from 190 countries, and talk to Kasem Prunratanmala, Head of Equity Research at Principal Malaysia Titans Plus Fund.

Interview: Jürgen Laartz, founder, and Alexandra Cosma, COO, EDU Malta

A five and a half year education (Batchelor + Masters) as a doctor for just €100,000? That is what is on offer from EDU Malta, a for-profit educational institute with statutes which commit it to working for the public good. It is working closely with Fresenius Helios and other German hospitals and is looking for hospital partners in other countries.  So how does it work, what are EDU’s plans and what role could this play in dealing with the massive world shortage of doctors?

Ukrainian operators calm, but foreign investment could falter

The eyes of the world have been on Ukraine recently, as the risk of a Russian invasion ramps up. HBI speaks to operators, private equity, and pharma in the region to see if nerves are being held, or fraying, and how what happens in the next few weeks might hit for-profit healthcare in the region.

IHH to “vigorously defend” $6.5bn lawsuit

Listed Malaysian hospital group IHH Healthcare says it will 'vigorously defend' a $6.5bn suit by US fund Emqore relating to the issuance of shares by IHH-owned Indian hospital group Fortis.

IDH enters South Asian market

Integrated Diagnostics Holdings is acquiring a 50% stake in one of Pakistan’s largest diagnostics providers, entering the country for the first time.

Find Us